Again, we are all 'assuming' which makes this all worse for
Again, we are all 'assuming' which makes this all worse for everyone. Until Management or the SEC or someone at the OTC comes out and tells us what exactly is going on, everything is a guess. However what we do know is some clowns dumped the stock down to .04 something at one point and it has never recovered.
Also again, it has been proven that sales of Excellegan has been in the millions so that product is a valid product. We have also had a paper on their Cancer testing for a 10 year study that shows it works. Both are valid. We have deals which are valid. We have a 500+ million worth of NUGENERX that sits out there. That is valid. So, there is something there. Products and science do exist. These are all facts that regardless of management, they do exist and have some impact to companies that can use them or at the very least they are viable to the needs outside, they just need to get out there.
If the Board of Directors ever gets a backbone or Joe ever decides he needs to step up or down and let someone take the reigns, maybe just maybe they can bring things to light. On the otherhand, if there is someone with deep pockets who believes these products and the science is worth anything, then we might have something as well.
And as I have said so many times, time will tell if we see anything from the products or the science or the shareholders will see anything positive out of all of this. In the end, it's a wait and see game for the most part and Joe if simply not helping matters at all and neither is the Board of Directors .
4
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Disclosure from Marlowe PLC The public opening position disclosure from Marlowe PLC brings vital information to investors and stakeholders. It serves as an essential document under the rules established by the Takeover Code. A disclosure like this outlines the interests stakeholders hold in relevant securities, especially when they represent 1% or...
Continue Reading
Harvard Extension School's #HESProud Campaign Achievements The Harvard Extension School (HES) proudly announces its victory with the #HESProud social media campaign, honored as the GOLD recipient of the UPCEA's Excellence in Marketing Award for 2024. This notable accolade it received celebrates the campaign's creativity and engagement, which resonated significantly across...
Continue Reading
AI in Customer Experience: Not Quite There Yet Let's dive into what TELUS Digital and Ryan Strategic Advisory's survey reveals: enterprises are tossing AI into their customer experience (CX) operations like confetti, yet they're fumbling when it comes to actually tracking if it’s doing any good. Most are relying on human agents propped up by AI, with a solid 61% rolling...
Continue Reading
Humana and Longevity Health Join Forces for Expanded Access In an important alliance, Humana Inc. (NYSE: HUM) and Longevity Health have unveiled a multi-state initiative set to enhance accessibility to Humana Together in Health, which is a Medicare Advantage Institutional Special Needs Plan (I-SNP). This collaboration focuses on providing personalized care to individuals...
Continue Reading
Groundbreaking Judgment in Niger Delta Oil Pollution Case In a significant ruling, the English High Court addressed ongoing litigation regarding oil pollution in the Niger Delta, focusing specifically on the Bille and Ogale regions. This decision, delivered by Justice May, aims to clarify complex legal issues and streamline the upcoming trial process. Facing off in this...
Continue Reading